AVE 0.00% 0.2¢ avecho biotechnology limited

new announcement coming thru, page-12

  1. 5,798 Posts.
    lightbulb Created with Sketch. 737
    Funny how quickly the knockers come out. Elixia is a product that along with other lines, will start generating revenue which will cover running costs of the company. This is their method to decrease reliance on cap raisings, which everyone jumps down managements throats about. We obviously just can't win.
    Take a look through the list of pipeline products on the other thread and take the time to work out which products will be used for a lower level revenue generator and which ones will be blockbuster deal makers.
    Also don't forget that is TVSN is one avenue that POH now have to go with and look for it's release into SE Asia and India in the 3rd Qtr.
    It's all part of a stratetgy, so take a step back and look at the big picture.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $973 486.2K

Buyers (Bids)

No. Vol. Price($)
11 6361102 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41925822 29
View Market Depth
Last trade - 10.27am 31/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.